Neurological manifestations of COVID-19: a review of what we know so far Panagiotis Gklinos Review 26 May 2020 Pages: 2485 - 2489
Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19 Kazimierz LogminMohamed KaramLars Wojtecki Letter to the Editors Open access 26 May 2020 Pages: 2490 - 2491
Post-infectious Guillain–Barré syndrome related to SARS-CoV-2 infection: a case report Nilo RivaTommaso RussoRaffaella Fazio Letter to the Editors 26 May 2020 Pages: 2492 - 2494
Miller–Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19) Jessica Fernández-DomínguezElena Ameijide-SanluisValentín Mateos Letter to the Editors 26 May 2020 Pages: 2495 - 2496
An integrated perspective linking physiological and psychological consequences of mild traumatic brain injury Harm Jan van der HornManon L. OutJoukje van der Naalt Review Open access 27 April 2019 Pages: 2497 - 2506
Parkinson’s disease and the gastrointestinal microbiome Michal LubomskiAi Huey TanCarolyn M. Sue Review 30 April 2019 Pages: 2507 - 2523
A nerve conduction study predicts the prognosis of sporadic amyotrophic lateral sclerosis Eriko ImaiTomohiko NakamuraMasahisa Katsuno Original Communication 04 May 2020 Pages: 2524 - 2532
Exome sequencing in 38 patients with intracranial aneurysms and subarachnoid hemorrhage Thomas SauvignyMalik AlawiGeorg Rosenberger Original Communication Open access 04 May 2020 Pages: 2533 - 2545
Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum Luísa Panadés-de OliveiraLaura Bermejo-GuerreroCristina Domínguez-González Original Communication 04 May 2020 Pages: 2546 - 2555
Lumboperitoneal shunt in idiopathic normal pressure hydrocephalus: a prospective controlled study Massimiliano TodiscoMarta PicasciaClaudio Pacchetti Original Communication 05 May 2020 Pages: 2556 - 2566
A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia Daniela Diaz-LucenaGeòrgia EscaramisFranc Llorens Original Communication 05 May 2020 Pages: 2567 - 2581
Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s disease Talia HermanMoria DaganJeffrey M. Hausdorff Original Communication 07 May 2020 Pages: 2582 - 2588
Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy Jiaqi DingKaixi RenJun Guo Original Communication 07 May 2020 Pages: 2589 - 2593
Neurofilament light chain as a potential biomarker of disease status in Friedreich ataxia Alexandra ClayKristin M. ObrochtaDavid R. Lynch Original Communication 08 May 2020 Pages: 2594 - 2598
Application of “Mentzer’s PML case definition” to natalizumab-treated patients in the setting of strict MRI-based pharmacovigilance Martijn T. WijburgClemens WarnkeMike P. Wattjes Original Communication 08 May 2020 Pages: 2599 - 2602
Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech Zeynep Idil SeckinJennifer L. WhitwellKeith A. Josephs Original Communication 09 May 2020 Pages: 2603 - 2611
Epilepsy in children with leukodystrophies Jie ZhangTingting BanYe Wu Original Communication 09 May 2020 Pages: 2612 - 2618
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent Marcus W. KochJop MostertLuanne Metz Original Communication 09 May 2020 Pages: 2619 - 2624
Cerebellar degeneration in adult spinal muscular atrophy patients Fabrício Castro de BorbaGiorgia QuerinPierre-François Pradat Original Communication 10 May 2020 Pages: 2625 - 2631
Posterior circulation stroke: machine learning-based detection of early ischemic changes in acute non-contrast CT scans Helge C. KniepPeter B. SpornsUta Hanning Original Communication Open access 11 May 2020 Pages: 2632 - 2641
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary? Elena TsantesE. CurtiF. Granella Original Communication 12 May 2020 Pages: 2642 - 2647
Screening for genetic mutations in patients with neuropathy without definite etiology is useful Braden VogtNizar ChahinChafic Karam Original Communication 12 May 2020 Pages: 2648 - 2654
Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD) Panayiota PetrochilosM. S. ElmalemC. Selai Original Communication Open access 14 May 2020 Pages: 2655 - 2666
Do patients with large vessel occlusion ischemic stroke harboring prestroke disability benefit from thrombectomy? Alice LarssonCamilla KarlssonKatarina Jood Original Communication Open access 14 May 2020 Pages: 2667 - 2674
Prevalence and risk factors of silent brain infarcts in patients with AF detected by 3T-MRI Irene Escudero-MartínezRafael F. OceteJoan Montaner Original Communication 14 May 2020 Pages: 2675 - 2682
Impact of environmental factors and physical activity on disability and quality of life in CIDP Pietro Emiliano DonedduElisa Bianchithe Italian CIDP Database Study Group Original Communication 19 May 2020 Pages: 2683 - 2691
Dopaminergic function in spinocerebellar ataxia type 6 patients with and without parkinsonism Yoshihiko HorimotoEmi HayashiHidehiro Kabasawa Original Communication 21 May 2020 Pages: 2692 - 2696
Pick’s disease: clinicopathologic characterization of 21 cases Parichita ChoudhuryEugene L. ScharfBradley F. Boeve Original Communication 21 May 2020 Pages: 2697 - 2704
A novel frameshift deletion in autosomal recessive SBF1-related syndromic neuropathy with necklace fibres Qiang GangConceição BettencourtHenry Houlden Original Communication Open access 22 May 2020 Pages: 2705 - 2712
Sonography of optic nerve sheath diameter identifies patients with middle cerebral artery infarction at risk of a malignant course: a pilot prospective observational study Piergiorgio LochnerKlaus FassbenderUmut Yilmaz Original Communication 22 May 2020 Pages: 2713 - 2720
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project Sandra Lopez-LeonYvonne GeissbühlerJoan K. Morris Original Communication Open access 22 May 2020 Pages: 2721 - 2731
SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia Alma OsmanovicMaylin WidjajaRuthild G. Weber Original Communication Open access 23 May 2020 Pages: 2732 - 2743
Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications Stefano GelibterLucia MoiolaMassimo Filippi Letter to the Editors 09 July 2020 Pages: 2744 - 2746
Comment on: “Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-Gaussian analysis” Daniela AndriutaAlexandre PerronOlivier Godefroy Letter to the Editors 08 July 2020 Pages: 2747 - 2748
Bi-allelic variants in PNPLA6 possibly associated with Parkinsonian features in addition to spastic paraplegia phenotype Kuntal SenMelesilika FinauPritha Ghosh Short Commentary 04 July 2020 Pages: 2749 - 2753
An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention Viorica ChelbanDaniela CatereniucHenry Houlden Neurological Update Open access 20 May 2020 Pages: 2754 - 2770
Emerging treatments for neuromyelitis optica spectrum disorder Ray Wynford-ThomasNeil P. Robertson Journal club Open access 22 July 2020 Pages: 2771 - 2773
Józefa Franciszka Joteyko (1866–1928) Katarzyna Pekacka-FalkowskaAnna Maria Pekacka-Egli Pioneers in Neurology Open access 20 August 2019 Pages: 2774 - 2775